Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 30, 2015 4:31 PM ET


Company Overview of Allergan Inc.

Executive Profile

David E. I. Pyott

Chairman and Chief Executive Officer, Allergan Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. David E. I. Pyott has been the Chairman and Chief Executive Officer of Allergan Inc. since April 2001 and January 1998 respectively. Mr. Pyott serves as the President of the Pan-American Ophthalmological Foundation. He serves as Vice Chairman of the Chief Executive Roundtable for UCI. He served as the President of Allergan Inc. from January 1998 to February 1, 2006 and again from March 27, 2011 to June 2013 and as the Chief Administrative Officer since August 1, ...

Corporate Headquarters

2525 Dupont Drive
Irvine, California 92612

United States

Phone: 714-246-4500
Fax: 714-246-6987

Board Members Memberships

Former Director
Director and Member of Investment & Finance Committee
Director At Large
Chairman and Chief Executive Officer
Lead Independent Director, Chairman of Compensation & Executive Personnel Committee and Member of Governance & Social Responsibility Committee
Former Independent Director and Member of Audit & Public Policy Committee
Former Director


University of Edinburgh in Scotland
London Business School

Other Affiliations

Annual Compensation

Total Annual Compensation$1,401,269

Stocks Options

All Other Compensation$52,136
Exercised Options$252,000
Exercised Options Value$21,915,760
Exercisable Options$2,265,200
Exercisable Options Value$343,106,749
Unexercisable Options$734,756
Unexercisable Options Value$79,105,693
Total Value of Options$444,128,201
Total Number of Options$3,251,956

Total Compensation

Total Annual Cash Compensation$3,674,205
Total Short Term Compensation$1,401,269
Other Long Term Compensation$52,136
Total Calculated Compensation$17,785,957

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Allergan Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at